propagermanium has been researched along with hypoxanthine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aso, H; Azumi, J; Doiyama, S; Nagata, K; Nakamura, T; Sakamoto, N; Shimada, Y; Takeda, T; Tokuji, Y; Yamaguchi, H | 1 |
1 other study(ies) available for propagermanium and hypoxanthine
Article | Year |
---|---|
Organogermanium suppresses cell death due to oxidative stress in normal human dermal fibroblasts.
Topics: Cell Death; Cells, Cultured; Chromatography, Liquid; Dose-Response Relationship, Drug; Fibroblasts; Gene Expression Regulation; Germanium; Humans; Hydrolysis; Hypoxanthine; Interleukin-6; Isotope Labeling; Microscopy; Nuclear Receptor Subfamily 4, Group A, Member 2; Organometallic Compounds; Oxidative Stress; Propionates; Skin; Tandem Mass Spectrometry; Xanthine Oxidase | 2019 |